Modulation of rotavirus severe gastroenteritis by the combination of probiotics and prebiotics

Archives of Microbiology

Volumn 199, Issue 7, 2017, Pages 953-961

  Gonzalez Ochoa, Guadalupe ^a   Flores Mendoza, Lilian K ^a   Icedo Garcia, Ramona ^a   Gomez Flores, Ricardo ^b   Tamez Guerra, Patricia ^b  

^a UNIVERSIDAD DE SONORA   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

Author keywords

Pathogenesis; Prebiotics; Probiotics; Rotavirus

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT; ANTIVIRUS AGENT; GLYCOPROTEIN; INULIN; NS28 PROTEIN, ROTAVIRUS; NSP1 PROTEIN, ROTAVIRUS; TOXIN; VIRAL PROTEIN;

BIFIDOBACTERIUM; COMBINATION DRUG THERAPY; DISEASE SEVERITY; HUMAN; IMMUNE EVASION; IMMUNOMODULATION; INNATE IMMUNITY; LACTOBACILLUS; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ROTAVIRUS; ROTAVIRUS INFECTION; VIRAL GASTROENTERITIS; VIRUS IMMUNITY; VIRUS PATHOGENESIS; CHILD; DIARRHEA; DRUG EFFECTS; FEMALE; GASTROENTERITIS; IMMUNOLOGY; INFANT; METABOLISM; PHYSIOLOGY; UTILIZATION; VIROLOGY;

ANTIVIRAL AGENTS; BIFIDOBACTERIUM; CHILD; DIARRHEA; FEMALE; GASTROENTERITIS; GLYCOPROTEINS; HUMANS; INFANT; INULIN; LACTOBACILLUS; PREBIOTICS; PROBIOTICS; ROTAVIRUS; ROTAVIRUS INFECTIONS; TOXINS, BIOLOGICAL; VIRAL NONSTRUCTURAL PROTEINS;

EID: 85021172277     PISSN: 03028933     EISSN: 1432072X     Source Type: Journal    
DOI: 10.1007/s00203-017-1400-3     Document Type: Review

References (56)

1. Arnold MM, Patton JT (2011) Diversity of interferon antagonist activities mediated by NSP1 proteins of different rotavirus strains. J Virol 85:1970–1979
2. Bagchi P et al (2010) Rotavirus nonstructural protein 1 suppresses virus-induced cellular apoptosis to facilitate viral growth by activating the cell survival pathways during early stages of infection. J Virol 84:6834–6845
3. Ball JM, Tian P, Zeng CQ, Morris AP, Estes MK (1996) Age-dependent diarrhea induced by a rotaviral nonstructural glycoprotein. Science 272:101
4. Barro M, Patton JT (2007) Rotavirus NSP1 inhibits expression of type I interferon by antagonizing the function of interferon regulatory factors IRF3, IRF5, and IRF7. J Virol 81:4473–4481
5. Bhowmick R, Halder UC, Chattopadhyay S, Nayak MK, Chawla-Sarkar M (2013) Rotavirus-encoded nonstructural protein 1 modulates cellular apoptotic machinery by targeting tumor suppressor protein p53. J Virol 87:6840–6850
6. Bines JE, Kirkwood CD (2015) Conquering rotavirus: from discovery to global vaccine implementation. J Paediatr Child Health 51:34–39
7. Blutt SE, Conner ME (2007) Rotavirus: to the gut and beyond! Curr Opin Gastroenterol 23:39–43
8. Boschi-Pinto C, Velebit L, Shibuya K (2008) Estimating child mortality due to diarrhoea in developing countries. Bull World Health Organ 86:710–717
9. Broquet AH, Hirata Y, McAllister CS, Kagnoff MF (2011) RIG-I/MDA5/MAVS are required to signal a protective IFN response in rotavirus-infected intestinal epithelium. J Immunol 186:1618–1626
10. Chhabra P et al (2013) Etiology of viral gastroenteritis in children <5 years of age in the United States, 2008–2009. J Infect Dis 208:790–800
11. Das S, Gupta PK, Das RR (2016) Efficacy and safety of Saccharomyces boulardii in acute rotavirus diarrhea: double blind randomized controlled trial from a developing country. J Trop Pediatr 62:464–470
12. Elliott EJ (2007) Acute gastroenteritis in children. BMJ Br Med J 334:35–40
13. Estes M, Greenberg H (2013) Rotaviruses. In: Knipe DM, Howley PM (eds) Fields virology. Lippincott Williams & Wilkins, Philadelphia
14. Finkbeiner SR et al (2009) Human stool contains a previously unrecognized diversity of novel astroviruses. Virol J 6:161
15. Franco MA, Tin C, Rott LS, VanCott JL, McGhee JR, Greenberg HB (1997) Evidence for CD8+ T-cell immunity to murine rotavirus in the absence of perforin, fas, and gamma interferon. J Virol 71:479–486
16. Franco MA, Angel J, Greenberg HB (2006) Immunity and correlates of protection for rotavirus vaccines. Vaccine 24:2718–2731
17. Gänzle MG, Höltzel A, Walter J, Jung G, Hammes WP (2000) Characterization of reutericyclin produced by Lactobacillus reuteri LTH2584. Appl Environ Microbiol 66:4325–4333
18. Gilger M, Matson D, Conner M, Rosenblatt H, Finegold M, Estes M (1992) Extraintestinal rotavirus infections in children with immunodeficiency. J Pediatr 120:912–917
19. Guérin-Danan C et al (2001) Food supplementation with milk fermented by Lactobacillus casei DN-114 001 protects suckling rats from rotavirus-associated diarrhea. J Nutr 131:111–117
20. Hagbom M et al (2011) Rotavirus stimulates release of serotonin (5-HT) from human enterochromaffin cells and activates brain structures involved in nausea and vomiting. PLoS Pathog 7:e1002115
21. Hester SN et al (2013) Human milk oligosaccharides inhibit rotavirus infectivity in vitro and in acutely infected piglets. Br J Nutr 110:1233–1242
22. Hostetler MA, Nakanishi AK, Whiteman PJ (2004) Gastroenteritis: an evidence-based approach to typical vomiting, diarrhea, and dehydration. Pediatr Emerg Med Pract 1:1–19
23. Ishizuka T et al (2016) Immunobiotic bifidobacteria strains modulate rotavirus immune response in porcine intestinal epitheliocytes via pattern recognition receptor signaling. PLoS One 11:e0152416
24. İşlek A, Sayar E, Yılmaz A, Baysan BÖ, Mutlu D, Artan R (2014) The role of Bifidobacterium lactis B94 plus inulin in the treatment of acute infectious diarrhea in children. Turk J Gastroenterol 25:628–633
25. Jain S, Vashistt J, Changotra H (2014) Rotaviruses: is their surveillance needed? Vaccine 32:3367–3378
26. Jiang JQ, He X-S, Feng N, Greenberg HB (2008) Qualitative and quantitative characteristics of rotavirus-specific CD8 T cells vary depending on the route of infection. J Virol 82:6812–6819
27. Jourdan N, Maurice M, Delautier D, Quero AM, Servin AL, Trugnan G (1997) Rotavirus is released from the apical surface of cultured human intestinal cells through nonconventional vesicular transport that bypasses the Golgi apparatus. J Virol 71:8268–8278
28. Kaila M, Isolauri E, Saxelin M, Arvilommi H, Vesikari T (1995) Viable versus inactivated lactobacillus strain GG in acute rotavirus diarrhoea. Arch Dis Child 72:51–53
29. Kang JY, Lee DK, Ha NJ, Shin HS (2015) Antiviral effects of Lactobacillus ruminis SPM0211 and Bifidobacterium longum SPM1205 and SPM1206 on rotavirus-infected Caco-2 cells and a neonatal mouse model. J Microbiol 53:796–803
30. Koo HL, Ajami N, Atmar RL, DuPont HL (2010) Noroviruses: the leading cause of gastroenteritis worldwide. Discov Med 10:61–70
31. Kuklin NA, Rott L, Feng N, Conner ME, Wagner N, Müller W, Greenberg HB (2001) Protective intestinal anti-rotavirus B cell immunity is dependent on α4β7 integrin expression but does not require IgA antibody production. J Immunol 166:1894–1902
32. Lee DK, Park JE, Kim MJ, Seo JG, Lee JH, Ha NJ (2015) Probiotic bacteria, B. longum and L. acidophilus inhibit infection by rotavirus in vitro and decrease the duration of diarrhea in pediatric patients. Clin Res Hepatol Gastroenterol 39:237–244
33. Li M et al (2014) Human milk oligosaccharides shorten rotavirus-induced diarrhea and modulate piglet mucosal immunity and colonic microbiota. ISME J 8:1609–1620
34. Liu L et al (2015) Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet 385:430–440
35. Lundgren O, Svensson L (2001) Pathogenesis of rotavirus diarrhea. Microbes Infect 3:1145–1156
36. Lundgren O, Peregrin AT, Persson K, Kordasti S, Uhnoo I, Svensson L (2000) Role of the enteric nervous system in the fluid and electrolyte secretion of rotavirus diarrhea. Science 287:491–495
37. Maragkoudakis PA, Chingwaru W, Gradisnik L, Tsakalidou E, Cencic A (2010) Lactic acid bacteria efficiently protect human and animal intestinal epithelial and immune cells from enteric virus infection. Int J Food Microbiol 141:S91–S97
38. Matthijnssens J et al (2008) Full genome-based classification of rotaviruses reveals a common origin between human Wa-Like and porcine rotavirus strains and human DS-1-like and bovine rotavirus strains. J Virol 82:3204–3219
39. Matthijnssens J, Otto PH, Ciarlet M, Desselberger U, Van Ranst M, Johne R (2012) VP6-sequence-based cutoff values as a criterion for rotavirus species demarcation. Arch Virol 157:1177–1182
40. Morelli M, Dennis AF, Patton JT (2015) Putative E3 ubiquitin ligase of human rotavirus inhibits NF-κB activation by using molecular mimicry to target β-TrCP. MBio 6:e02490–e02514
41. Olaya Galán NN, Ulloa Rubiano JC, Velez Reyes FA, Duarte F, Karem P, Salas Cárdenas SP, Gutierrez Fernandez MF (2016) In vitro antiviral activity of Lactobacillus casei and Bifidobacterium adolescentis against rotavirus infection monitored by NSP4 protein production. J Appl Microbiol 120:1041–1051
42. + absorption. Pflugers Arch 461:579–589
43. Rahman M et al (2007) Evolutionary history and global spread of the emerging G12 human rotaviruses. J Virol 81:2382–2390
44. Ramig RF (2004) Pathogenesis of intestinal and systemic rotavirus infection. J Virol 78:10213–10220
45. Rezaei M, Sohrabi A, Edalat R, Siadat SD, Gomari H, Rezaei M, Gilani SM (2012) Molecular epidemiology of acute gastroenteritis caused by subgenus F (40, 41) enteric adenoviruses in inpatient children. Lab Med 43:10–15
46. Rigo-Adrover M et al (2016) A combination of scGOS/lcFOS with Bifidobacterium breve M-16V protects suckling rats from rotavirus gastroenteritis. Eur J Nutr 56:1657–1670
47. Rigo-Adrover M et al (2017) A fermented milk concentrate and a combination of short-chain galacto-oligosaccharides/long-chain fructo-oligosaccharides/pectin-derived acidic oligosaccharides protect suckling rats from rotavirus gastroenteritis. Br J Nutr 117:209–217
48. Santos N, Hoshino Y (2005) Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 15:29–56
49. Saxena K et al (2016) Human intestinal enteroids: a new model to study human rotavirus infection, host restriction, and pathophysiology. J Virol 90:43–56
50. Sdiri-Loulizi K et al (2011) Molecular detection of genogroup I sapovirus in Tunisian children suffering from acute gastroenteritis. Virus Genes 43:6–12
51. Servin AL (2004) Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev 28:405–440
52. Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD (2012) 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 12:136–141
53. Varyukhina S et al (2012) Glycan-modifying bacteria-derived soluble factors from Bacteroides thetaiotaomicron and Lactobacillus casei inhibit rotavirus infection in human intestinal cells. Microbes Infect 14:273–278
54. Vlasova AN, Kandasamy S, Chattha KS, Rajashekara G, Saif LJ (2016) Comparison of probiotic lactobacilli and bifidobacteria effects, immune responses and rotavirus vaccines and infection in different host species. Vet Immunol Immunopathol 172:72–84
55. Williams M, Rosé J, Rott L, Franco M, Greenberg H, Butcher E (1998) The memory B cell subset that is responsible for the mucosal IgA response and humoral immunity to rotavirus expresses the mucosal homing receptor, α 4 β 7. J Immunol 161:4227–4235
56. Yasui H, Kiyoshima J, Ushijima H (1995) Passive protection against rotavirus-induced diarrhea of mouse pups born to and nursed by dams fed Bifidobacterium breve YIT4064. J Infect Dis 172:403–409